## 



|CONTENTS|||Page|
|---|---|---|---|
|Reference and administrative<br>details||||
|Chairman's|Report|||
|Trustees'<br>Report||||
|Independent|auditors<br>report||32|
|Consolidated|statement<br>of financial|activities|35|
|Consolidated|and charity balance sheets||36|
|Consolidated|cash flow statement||37|
|Notes to the|financial<br>statements||38|





|Charity Name|Charity Name|Rennie Grove|Hospice Care|Hospice Care|Hospice Care|||||
|---|---|---|---|---|---|---|---|---|---|
|Charity Number||1140386||||||||
|Company|Number|07479930||||||||
|Registered|Office|Grove House||||||||
|||Waverley<br>Road||||||||
|||St Albans||||||||
|||Hertfordshire,<br>AL3|||SQX|||||
|Trustees||Prof S Spiro<br>(Chairman)||||||||
|||Mr C Inman<br>OBE|||(Vice Chairman)|||||
|||Mr 3 Wroe (Treasurer)||||||||
|||Mr S Hamill||||||||
|||Mr M Ferguson||||||||
|||Dr A Wainwright||||||||
|||Mrs 3 Macleod||||||||
|||Dr L Baillie||||||||
|||Mrs P Nightingale|||MBE|||||
|||Mr E Pillinger||||||||
|||Mr G Upward||||||||
|Company|Secretary|Mrs J MacLeod||||||||
|Chief Executive||Mr DS Marks||||||||
|Senior Management||Ms R Ahmad||||||||
|||Mrs D Gould||||||||
|||Mrs T Hancock||||||||
|||Mrs S Howard||||||||
|||Mrs K Pezet||||||||
|||Mrs P Pickersgill||||||||
|||Mrs P Scott||||||||
|Auditors||Haysmacintyre||LLP||||||
|||10Queen Street Place||||||||
|||London,<br>EC4R|1AG|||||||
|Bankers||Barclays Bank|pic|||||||
|||22-24<br>Upper|Marlborough|||Road,||||
|||St Albans,<br>Herts||AL1 3AL||||||
|Solicitors||Sherrards<br>Solicitors|||||Matthew|Waite iz Co||
|||45 Grosvenor|Road||||Ariel House|||
|||St Albans|||||Frogmore|Street||
|||Herts,<br>AL1 3AW|||||Tring, Herts,||HP23 SAU|





## 



## 

## 

## 



## 



## 

## 



## 

## 

## 



## 

## 

## 

## 

## 






## 

## 

## 



## 

## 

## 



## 

## 



## 



## 

## 

## 

## 

## 



## 



## 

## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 



|||0||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|(nlO<br>CQz<br>CL<br>~Q<br>CJ<br>E<br>CJ<br>Z<br>OL Z<br>9 UJ<br>) UJ<br>Ch<br>OC<br>O<br>CQ<br>~III)<br>Q UJ<br>UJ UJ Z<br>Zhl-<br>ZDR<br>UJ<br>CL0<br>OC<br>I<br>IL|L<br>E <br>On <br>Id<br>Ih<br>CL'|Ql<br>IJ<br>55<br>n5<br>+<br>Ofl<br>Ce<br>Qi0<br>td<br>(U<br>E<br>n5O<br>r(5<br>Ql<br>td<br>Ql<br>Qi<br>0<br>Ql<br>E<br>Ql<br>CL<br>QlE<br>(U<br>Ofl<br>tdC<br>td<br>E<br>'C<br>M<br>C<br>IlleL<br>Ql<br>0L0<br>Zl<br>0<br>CL<br>Qi<br>i<br>n5<br>e<br>(U<br>Ih<br> I—<br> 0<br>(L<br>\-(50<br>Qi<br> I-|e<br>Id<br>I<br>tll<br>nf<br>e<br>4<br>e<br>(50<br>(55e<br>I—<br>I<br>0<br>IU<br>+<br>QlO.a<br>tde<br>M<br>C<br>UL<br>Qi<br>CC<br>D<br>lde<br>0<br>+e<br>+<br>Ofl<br>e<br>c<br>4/<br>I<br>n5<br>C<br>u 0<br>I/I<br>I/I<br>E<br>0 u<br>0<br>M<br>0cc<br>U<br>td<br>De u<br>0 u<br>ecEc<br>td<br>Ql<br>Ih<br>Ih<br>E c<br>nl<br>OA<br>Id<br>C(5 e<br>I/Ie<br>I/I<br>I/I<br>'O<br>n5|C0<br>'O<br>nl0<br>COe<br>e<br>nl0<br>td<br>I0<br>CLa<br>OC<br>nl<br>C0<br>V<br>Id<br>OA<br>C<br>+td<br>Oil<br>E<br>DC<br>'C<br>e<br>) <br>e<br>i<br>e<br>I/I <br>Ql<br>4/<br>4/<br>E <br>E<br>U <br>u<br>C<br>Ci-<br>0<br>e.v <br>.c <br>"0<br>c <br>nl<br>NC0<br>u<br>td<br>p<br>D <br>n5 <br>~ <br>I/I<br>CL <br>V<br>C <br>Qi|I/I<br> 'v<br> 0<br>C<br> E<br>M<br> e<br>E<br>I<br>E<br> a<br> E<br>E<br>td<br> e<br>Qi<br>E<br>5on<br>ld<br> g<br> p<br> 'C<br> I/I<br>Qlc<br> e<br>Id<br>E|QlV<br>:05<br>On<br>e<br>ie'0<br>Ee<br>+0<br>4/<br>e<br>tdV0<br>td<br>ie<br>+<br>OA<br>OA<br>n5C<br>n5<br>E<br>0<br>td<br>Jn<br>e<br>I/I<br>0C<br>on<br>a e<br>e<br>td<br>I<br>0<br>td<br>O<br>(5<br>C<br>I/I<br>Q<br>h<br>E<br>0 e<br>e 0<br>+e<br>U<br>C<br>On C<br>'In 0<br>e u<br>O<br>V<br>nl<br>e<br>M<br>e c<br>td<br>E<br>on<br>E 40<br>0 E<br>OC<br>tg<br>(U<br>O<br>Qi<br>\-<br>C0<br>U<br>I—D{<br>0 e<br>CO<br>C<br>c e<br>I—|e<br>Ve<br>0<br>U<br>M<br>Qi<br>4/<br>td<br>4/<br>Qle<br>E0<br>El<br>fd<br>e<br>0<br>LI<br>Ql<br>C<br>Ql<br>CL<br>(L0<br>ee<br>IL<br>00<br>0<br>55e<br>'0e<br>e<br>'C<br>e<br>e<br>e<br>Jp<br>'C<br>U<br>QlO<br>CL<br>n5<br>I<br>DA<br>(5<br>n5<br>CL<br>On<br>04<br>Ql<br>I—|0<br>C<br>Ql<br>Ql<br>On<br>lg<br>Ql<br>0<br>Qi<br>EL<br>Qi<br>CL<br>I-0<br>OCN0<br>tdV<br>CL<br>E<br>rd<br>0<br>+IdI-<br>QlO.0<br>DC<br>td<br>td<br>U<br>C<br>DnC<br>n5<br>e<br>e<br>e<br>QiU<br>(U <br>(5<br>U<br>U<br>0<br>e<br>Ql<br>D<br>D <br>Ql<br>IJ<br>Q. <br>In<br>Idc<br>I)<br>0|e<br>td<br>4/<br>rd<br>on<br>V<br>n5<br>In<br> 'C<br>td<br> UCi<br>c<br> u(5|0<br>td<br>Dll<br>+V<br>O.<br>E<br>td<br>Ql<br>0<br>O|C<br>z 0<br>OC<br>peUL<br>c e<br>E<br>ld<br>e e<br>On<br>e<br>U<br>OL<br>e<br>td<br>Ihe0C<br>p<br>Qi0<br>I/I<br>LI<br>U U<br>N<br>e<br>e<br>J3<br>Qi<br>nl<br>Ql e<br>Ql<br>Id<br>C 0<br>0<br>Q<br>0<br>e)<br>U<br>C<br>Qi<br>Qi<br>(5<br>I/I<br>C<br>(U<br>e 0<br>aU<br>o<br>Pa<br>Le c<br>4<br>Id<br>C<br>C 9<br>I/I<br>u<br>E<br>N<br>e c<br>nl<br>0),d<br>Q<br>nl<br>e E<br>Cl<br>(5 L<br>OA<br>In<br>I/I'C<br>CL<br>(5|Qi<br>C ec<br>U 4~<br>(5<br>Ih<br>e<br>t5<br>x,u<br>ee<br>U<br>ld<br>QlD<br>nn<br>L CI<br>0 (4<br>U O<br>r4<br>(U<br>M<br>C<br>C<br>'e 'C<br>on 0<br>)<br>I/I'C<br>Nc<br>td<br>+<br>in<br>Dn<br>nl c<br>e 'on<br>Id<br>Id<br>o E<br>td0<br>e<br>LI<br>L<br>Ql<br>tdU<br>V<br>Ql<br>VeaD<br>E 0<br>4/<br>tdV<br>Qc<br>Id<br>C<br>Dn<br>'ih 0<br>ldIJ2<br>U<br>n-0<br>Ql<br>e<br>0<br>I<br>rd<br>L<br>Ql<br>I/I<br>Qi<br>c 'K|C<br>Ql<br>E<br>Qi<br>0M<br>+<br>V<br>F% <br>u<br>(5 <br>UJ0<br>CLe <br>4/ <br>td<br>IO. <br>Q<br>CL<br>Id0 <br>I/I<br>QIUU<br>Id<br>nl <br>0 <br>M<br>C<br>E0 <br>0 <br>E<br>0<br>U<br>u<br>g <br>I/I <br>e<br>4-/<br>O. <br>0|D<br>Qi<br>O<br> E<br>N<br> 0<br>Ue<br> e<br> )<br> M<br>UQ<br>N<br> e<br>Qi<br>Ofl<br>Ofl<br> e<br>c<br>n<br>nl<br> Jn<br> '0<br>ue<br>U<br>Id<br> E<br> 0<br> eU<br> 0|I<br>0 <br>0<br>0 <br>C<br>Qi<br>e <br>0 <br>c <br>nn-<br>td<br>I/I<br>QI<br>0 <br>0<br>0<br>U<br>Qi<br>L<br>'e <br>4/ <br>C <br>n5<br>E<br>e<br>0<br>ML<br>Id<br>OL<br>ld<br>0I-<br>e<br>+0<br>0e<br>Ih0ax|Ih<br> D<br>D<br> e<br>0<br>lh<br> )<br> e<br> M<br> e<br>e<br>O<br>Id<br>On<br> c<br> 0<br> e<br>Qj<br> 0<br>N|De<br>Ql<br>LI )<br>c e<br>fd<br>gnC<br>(U<br>u<br>ld<br>I/I<br>Id<br>Ql<br>I/I<br>L<br>eU<br>In<br>2 e<br>QiN u<br>I/I<br>E<br>I/I<br>U<br>v e<br>U<br>n5LQ<br>N<br>M 0<br>C<br>Ve<br>p<br>C<br>0 e.X<br>rd<br>E<br>ESe<br>Q<br>I<br>L<br>U<br>td|





|||i<br>o ~E<br>td<br>C<br>a<br>Q 0<br>fu<br>0<br>D 0<br>QQ<br>X<br>tll<br>nl<br>U<br>Q c<br>Q<br>C<br>4-<br>E<br>on<br>0u 0<br>L E<br>0 0u<br>()<br>&C<br>rV<br>onC<br>'C83<br>C<br>Ql<br>I/I )<br>I/I<br>Q<br>E u<br>td<br>tV<br>(O<br>cV<br>I/I<br>on (0<br>f«t<br>C 0<br>v-<br>C<br>N, p<br>C<br>N<br>E<br>Ql 0<br>e<br>0<br>uf<br>ec<br>Qi-<br>+<br>0<br>0<br>Ih<br>Q/<br>({I<br>E<br>M<br>Q<br>Q<br>Q<br>QlI<br>ff-0|i<br>o ~E<br>td<br>C<br>a<br>Q 0<br>fu<br>0<br>D 0<br>QQ<br>X<br>tll<br>nl<br>U<br>Q c<br>Q<br>C<br>4-<br>E<br>on<br>0u 0<br>L E<br>0 0u<br>()<br>&C<br>rV<br>onC<br>'C83<br>C<br>Ql<br>I/I )<br>I/I<br>Q<br>E u<br>td<br>tV<br>(O<br>cV<br>I/I<br>on (0<br>f«t<br>C 0<br>v-<br>C<br>N, p<br>C<br>N<br>E<br>Ql 0<br>e<br>0<br>uf<br>ec<br>Qi-<br>+<br>0<br>0<br>Ih<br>Q/<br>({I<br>E<br>M<br>Q<br>Q<br>Q<br>QlI<br>ff-0|IO<br>Uc<br>IO<br>E<br>0<br>)<br>IO<br>i0aa<br>C<br>Q<br>UE|Zl<br>tdC<br>lau0<br>I/I|0 <br>C <br>QlU<br>C <br>Q <br>C<br>0V<br>C<br>u<br>p<br>C<br>2 <br>td<br>Q<br>i<br>Q<br>u$|&O<br>V<br>nlC{0<br> 0<br> 0<br>N<br> '{<br> 0C<br>Ql<br>ta<br>Q<br>fhi<br>C<br> D<br>on<br>C<br>i<br> ~p|&LI<br>I/I0<br>V<br>Q <br>N<br>0C<br>on <br>0<br>C<br>&4<br>c4 <br>(0<br>C <br>ND<br>C|Q<br>Ql<br>({I<br>Ih<br>0u<br>(LI<br> o<br>i-<br>Q<br>C<br> e<br>I<br>C<br>'0<br>C<br> e<br> 0<br>C0<br> E|u<br>Ql<br>uQ<br>on<br>ta<br>Ql<br>QlQ<br>E|QU<br>0<br>i-0 <br>ta<br>U<br>U <br>0<br>0<br>'5<br>Q<br>JJ<br>U<br>laa <br>nl<br>nl<br>fa<br>00 <br>Q <br>D <br>C|0<br>nl<br>uC<br> 0<br>Q/<br>QQ<br>Ql<br>J<br>c<br>C<br> 0<br> u<br> (0<br>f«t<br>&0<br>f«t<br>C<br>Q<br>Q<br>U <br>la<br>+<br>0<br>Q<br>0<br>L<br>')<br>Q <br>tll<br>on <br>fu<br>IU|C<br>Q<br>CQ<br>VC<br> u<br>tll<br>fa<br>Q<br>C<br>nl<br>on<br>&U<br>C<br>fa<br> 0<br>V<br>nlo.<br>taV<br> D<br>ca<br>Ql|Q<br>C<br>Q0<br>rV<br>Cl<br>r4<br>M<br>C<br>QC0DQ<br>QC!<br>Q<br>z <br>CC<br>Q'0|I/I<br>C<br> E<br>Q)<br>UIa<br>U|D<br>(LI<br>QlC<br>I/I o<br>Q o<br>M u<br>C<br>ta<br>'0<br>N<br>Q<br>'+<br>0<br>taa<br>Q<br>I/ICU e<br>Q<br>Q/<br>on<br>(LI<br>U<br>0<br>I/I<br>E e<br>QC<br>cV<br>t«t<br>co<br>rn<br>0<br>4<br>I-|D<br>(LI<br>QlC<br>I/I o<br>Q o<br>M u<br>C<br>ta<br>'0<br>N<br>Q<br>'+<br>0<br>taa<br>Q<br>I/ICU e<br>Q<br>Q/<br>on<br>(LI<br>U<br>0<br>I/I<br>E e<br>QC<br>cV<br>t«t<br>co<br>rn<br>0<br>4<br>I-|'0<br>QI<br>Oll<br>fa<br>V<br>Q<br>N<br>tll<br>0 <br>Q<br>C <br>Q <br>o<br>a<br>Q<br>u<br>fa|I-<br>Q<br>Ql<br>Q<br>Q<br> L<br>Q<br> p<br> u<br>Ql<br>J3<br>Ia<br>Q<br>W<br>N<br>C<br>Ql<br>ta<br> a|O'I<br>OA<br>C<br>ih<br>VC<br>E<br>V<br>U|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||uUIao.<br>E<br>IUuCQ<br>0<br>(L|C<br>Q 0<br>E<br>U<br>o<br>D<br>C<br>N u<br>U<br>I<br>ta<br>Ql<br>U<br>U<br>Eop<br>o<br>Q<br>C<br>ta<br>NN<br>CL g<br>O<br>4<br>Ql<br>C<br>Cf<br>-too «{<br>)<br>P-<br>0 D<br>rV<br>O-C<br>(O<br>C0 &0<br>I- u<br>rv|C<br>IO<br>\-<br>a<br>u<br>+C<br>Q<br>u<br>u <br>0<br>'e <br>e<br>Q|C<br>I/I<br>Ql<br>U<br>Ql<br>Ql<br>Q<br>Ih<br>0<br> u<br> o<br>C<br>0|I/I<br>Q<br>U<br>I/I<br>ta<br>U<br>Q<br>0<br>CL<br>Ih<br>O<br> u||||||0<br>0 <br>Q <br>N <br>Q <br>O. <br>fa <br>QI<br>N <br>Pn <br>Ql<br>O. <br>C<br>V <br>C <br>e <br>C<br>LL|)<br>ta<br>or<br>N<br> C P<br> onQ<br>D<br> u<br> 5<br>I<br> UQ<br>0<br>Ql<br> u<br>Q D<br> - 0<br> u<br>U<br>C0<br> U<br>IU<br>0<br> ),<br>IU<br> u<br>U<br> =<br>IU<br>V|Q<br>ta<br>I/I<br>u<br>I/I <br>0<br>ta <br>0' <br>Ql<br>Co<br>V<br>hlo.|I/I<br>IU<br>Q<br>I/I<br>td<br> u<br>CQ<br>C<br> o.<br>Q<br> u<br>Q)<br>DQ<br>Q|0<br>M<br>Q<br>Q<br>D<br>Ia<br>taQ<br>Q/<br>M<br>C<br>Vta <br>a <br>E|«-<br> e<br> u|||||
|(ft<br>Cf<br>tnzO<br>~gO<br>E<br>O<br>t&I||C<br>Itl<br>td<br>Q<br>td 4-<br>CU<br>td<br>I/IIh0<br>E E<br>Ql<br>I|||||||||CC <br>ttl<br>Ql<br>U<br>I|+0<br>nl<br>IU<br>V<br>C<br>C<br>C<br>U<br>V<br> eu|||||||||
|(IIO I- CI<br>z {Q!2<br>~ 0 tlt<br>~ {L {L/<br>g Ill g<br>~{II)<br>U LI<br>ttl LI Z<br>Zh{-<br>2 2 {L'<br>lll g9<br>L I<br>U.||E<br>~MQ<br>'P 0<br>Q e u<br>E ),-<br>onC<br>0 Z)<br>'fh<br>o<br>C<br>'FaP<br>0<br>I/I<br>IU<br>ch<br>C'<br>(L|||||||||0 «- P<br>4-<br>I<br>c o<br>Ql 0<br>E +<br>0<br>C0<br>ep<br>&O<br>Ql<br>ta<br>I<br>0<br>i<br>CEg||||||||||





|||||I<br>Qr<br>0 U<br>td<br>Qr<br>Ql<br>UIa(1 4J<br>0|ta|0<br>C<br>I|Q/<br>0<br>0C|0<br>QlV<br>ta<br>Y1||40O.<br>O.<br>U|Ia<br>Otl<br>D<br>0<br>QlU||td<br>0<br>E <br>Qr<br>C|u<br>'on<br>D||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||C0<br>Ia<br>on<br>R|I/!<br>Ql<br>Qr<br>td<br>U<br>0<br>Ql<br>p.g<br>4J<br>I<br>U<br>Qr<br>Ia<br>I/I<br>ttlD<br>Qr<br>I/!<br>4J<br>Ql<br>IU<br>p<br>CL<br>Qr<br>e<br>UC<br>)<br>ta<br>ta<br>CL<br>E<br>O|taC<br>D <br>Ql<br>Qt<br>Q/<br>Ia<br>V<br>I/I<br>nl<br>U<br>u<br>o.|ra<br> 0<br>Qr<br>Uta<br>C'<br>Q<br>Ql<br>U<br>Ql<br>In<br>ta<br>Ql<br> 0|I/I<br>I/I<br>QrU<br>U<br>0E<br>e<br>0 <br>E<br>Ql<br>I/I<br>C<br>Ql|C<br>Q<br>Itl<br>V<br>C<br>Ql<br>Ia<br>40<br>Uta<br> 0<br>ta<br>C<br>Q<br>td<br>U<br>C|I/I<br>an<br>Qr <br>Ue <br>c <br>0<br>In <br>C0 <br>V<br>C <br>Qt<br>c <br>tll|art<br>QtU<br> p<br> n-0<br>I/I<br> 0L<br>Ug<br> 0<br>on<br>C<br> e<br> .M<br> e|fa<br>Q/0<br>rd<br>0<br>0<br>J2<br>rtl<br>0U<br>0<br>E<br>0<br>au<br>Ql<br>Qr0<br>E|U<br>Qr|Ia<br>Iau <br>In<br>Qr<br>E<br>ta<br>M<br>0<br>C <br>M<br>W|td<br> 0<br>Zl<br>nl<br>I/I<br>E<br>Qr<br>4-I<br>I/I<br>O<br>on<br> 0<br>o<br>) <br>0<br> e|U<br> IJ<br>U<br>Ia<br>CL|
||||4JV<br>td<br>QL<br>E<br>ta<br>C<br>Ql<br>0<br>(L|'0<br>C<br>ta<br>n0<br>C<br>In, nr<br>Qt<br>4Ju{e 0<br>C<br>C<br>Ia 0<br>.V uta<br>E<br>M 0<br>I/!<br>C<br>0c<br>nlC<br>Pn<br>an<br>Ql<br>c(|Qt<br>C<br>n/<br>on<br>C<br>nl<br>ta<br>u<br>ep<br>I/!<br>Q/<br>0<br>CL <br>0<br>In|C<br>Ql<br>e<br>CL<br>IU<br>Q/<br>U<br>IU<br>Q/<br>n<br>In<br>Q<br> D<br>Qr<br>Ql<br>C|nl<br>ta <br>e<br>- <br>y<br>Ql)<br>I<br>n/ <br>I/I<br>eV<br>u<br>Qt <br>4J0 <br>nl<br>4J<br>IU|C<br> p<br>U<br>nl<br>CL<br> E<br>Qt<br>L<br>Qr<br> ).<br>Qr<br>Ia<br> C'0<br> 0<br>ta<br>Qt|u<br>C <br>Qt<br>Ia<br>CLo<br>an<br>Qt <br>I/I<br>Qr0<br>0 <br>0<br>0|C<br> .0<br>4J<br>Ia<br>C<br>taU<br> 'C<br>On<br> 4J<br>Q/<br>C<br> e|one<br>E<br>Itl<br> D|||||
|||(II(0<br>Ia(2||||||||||||||
|||CJ||||||||||||||
|o||X||||||||||||||
|OI||||||||||||||||
|((lg I-6<br>222<br>9 III<br>) IL<br>IQ/<br>o~m~<br>U ~||||4<br>Ll<br>Ql||||||||||||
|2 <br>III<br>IL|D <br>IQ/ <br> I|IQ<br> 0<br>IL||Ql<br>Cl<br>VI||||||||||||





## 

## 




## 

## 

## 



## 



## 

## 

|||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|
|||Funds|Funds|2021|2020|
||Notes|E|E|E|E|
|INCOME FROM:||||||
|Donations<br>and legacies||3,305,212|460,720|3,765,932|3,227,882|
|Charitable<br>activities||||||
|NHS funding||998,707||998,707|1,042,574|
|Rapid Personalised<br>Care||1,153,620||1,153,620|2,165,914|
|Other income from charitable<br>activities|||3,055,245|3,055,245|346,744|
|Other trading activities||||||
|Events ik community||486,440|4,670|491,110|609,894|
|Retail income||830,008||830,008|3,279,412|
|Investments||868|9,308|10,176|15,610|
|Other||||||
|Hospice Lottery Partnership||435,704||435,704|450,000|
|Other income||1,120,982||1,120,982|472,709|
|Total income||8,331,541|3,529,943|11,861,484|11,610,739|
|EXPENDITURE ON:||||||
|Raising funds||||||
|Donations<br>and legacies||841,506||841,506|929,562|
|Fundraising<br>activities||2,296,927||2,296,927|2,809,523|
|Charitable<br>activities||||||
|Patient care||1,830,390|2,632,667|4,463,057|4,532,446|
|Rapid Personalised<br>Care||1,175,905||1,175,905|1,870,570|
|Totalexpenditure|5|6,144,728|2,632,667|8,777,395|10,142,101|
|Net gains/(losses)<br>on investments||463,389|(21,243)|442,146|(188,985)|
|Net income/(expenditure)|7|2,650,201|876,033|3,526,235|1,279,653|
|Other recognised<br>gains/(losses)||||||
|Net movement<br>in funds||2,650,201|876,033|3,526,235|1,279,653|
|Funds brought forward||6,039,071|2,066,482|8,105,553|6,825,900|
|Funds at 31 March 2021||8,689,272|2,942,515|11,631,788|8,105,553|





||||Group|Group|Charity|Charity|
|---|---|---|---|---|---|---|
||||2021|2020|2021|2020|
|||Notes|E|E|E|E|
|FIXEDASSETS|||||||
|Intangible<br>fixed assets||11|100,000|200,000|100,000|200,000|
|Tangible fixed assets||12|2,642,165|2,567,461|2,101,454|2,020,158|
|Investments||13|2,796,198|2,359,925|2,796,200|2,359,927|
||||5,538,363|5,127,386|4,997,654|4,580,085|
|CURRENT ASSETS|||||||
|Stock||14|51,000|50,181|||
|Debtors||15|2,951,974|2,611,697|2,999,427|2,706,143|
|Cash at bank and in hand|||4,903,656|1,774,330|4,840,829|1,707,007|
||||7,906,630|4,436,208|7,840,256|4,413,150|
|CURRENT LIABILITIES|||||||
|CREDITORS: amounts|falling due||||||
|within one year||16a|(1,063,205)|(1,458,041)|(1,059,245)|(1,452,959)|
|NE'T CURRENT ASSETS|||6,843,425|2,978,167|6,781,011|2,960,191|
|Total assets less current liabilities|||12,381,788|8,105,553|11,778,665|7,540,276|
|CREDITORS: amounts|falling due||||||
|after more than one year||16b|(750,000)||(750,000)||
|Net Assets|||11,631,788|8,105,553|11,028,665|7,540,277|
|FUNDS|||||||
|UNRESTRICTED FUNDS|||||||
|General fund|||8,539,172|5,795,412|8,476,761|5,777,438|
|Designated<br>funds|||||||
|-<br>Equipment|||150,101|243,659|150,101|243,659|
|- IT project|||||||
|||18|8,689,273|6,039,071|8,626,862|6,021,097|
|RESTRICTED FUNDS||18|2,942,515|2,066,482|2,401,803|1,519,179|
|||18|11,631,788|8,105,553|11,028,665|7,540,276|





## 

||||||||Notes|2021|2021|2020|
|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||E|
|Cash flows from operating||activities||||||2,559,918||764,429|
|Cash flows from investing||activities|||||||||
|Interest<br>received|||||||||439|4,873|
|Dividends<br>received|||||||||9,737|10,737|
|Proceeds from sale of PPE||||||||||9,774|
|Purchase oftangible<br>fixed assets||||||||(196,640)||(787,489)|
|Purchase of investments||||||||||(14,877)|
|Proceeds from sale of investments|||||||||5,873|4,896|
|Cash provided<br>by/(used|in) investing|||activities||||(180,593)||(772,086)|
|Cash flows from financing|||activities||||||||
|Proceeds from loan||||||||750,000|||
|Increase (decrease)<br>in|cash and cash|||equivalents||in||3,129,326||(7,657)|
|the year|||||||||||
|Cash and cash equivalents|at|the|beginning|ofthe year||||1,774,330||1,781,987|
|TOTAL CASH AND CASH|EQUIVALENTS AT THE||||END|||4,903,656||1,774,330|
|OF THE YEAR|||||||||||
|Analysis ofmovements|in|net|cash||||||||
|||||||2020|Cash Flows|||New<br>2021|
||||||||||Borrowing||
|||||||||||E|
|Cash at bank|||||1,774,330|||3,129,326||4,903,656|
|Loan|||||||||(750,000)<br>(750,000)||
|Total|||||ig774~330||3I129I326||(750~000)<br>4I153I656||





## 

## 



## 

## 

## 

## 

## 

## 



## 

|Freehold|land|0%|
|---|---|---|
|Freehold|buildings|over 50years from the date offirst use|
|Leasehold|property|over the term ofthe lease|
|Leasehold|improvements|over the term ofthe lease|
|Motor vehicles||25% - 33%straight<br>line|
|Fixtures and fittings||20% straight<br>line|
|Tools and|equipment|25% —33%straight<br>line|
|Car park||over 10years from the date offirst use|



## 

## 

## 

## 



## 

## 

## 

## 

## 



|2.|ANALYSIS OF|INCOME (2021)|INCOME (2021)|Unrestricted|Restricted|Total|
|---|---|---|---|---|---|---|
|||||funds|funds|2021|
|||||E|E|E|
||Legacies|||1,213,234|50,000|1,263,234|
||Donations|||2,091,978|410,720|2,502,698|
||Total legacies|and|donations|3,305,212|460,720|3,765,932|
||Events|||486,440|4,670|491,110|
||Trading|||830,008||830,008|
||Total trading|and|fundraising|1,316,448|4,670|1,321,118|
||Investment<br>income||receivable|429||429|
||Interest receivable|||439|9,308|9,747|
||Total investment||income|868|9,308|10,176|
||Income from|donations,<br>legacies,|||||
||trading, fundraising<br>S.investments|||4,622,527|474,699|5,097,226|
||ANALYSIS OF|INCOME (2020)||Unrestricted|Restricted|Total|
|||||funds|funds|2020|
|||||E|E|E|
||Legacies|||1,056,011||1,056,011|
||Donations|||1,525,053|646,818|2,171,871|
||Total legacies|and|donations|2,581,064|646,818|3,227,882|
||Events|||605,944|3,950|609,894|
||Trading|||3,279,412||3,279,412|
||Total trading|and|fundraising|3,885,356|3,950|3,889,306|
||Investment<br>income||receivable|1,429||1,429|
||Interest receivable|||4,873|9,308|14,181|
||Total investment||income|6,302|9,308|15,610|
||Income from|donations,<br>legacies,|||||
||trading, fundraising<br>h investments|||6,472,722|660,076|7,132,798|





|3.|INCOME FROM C|H|ARITABL|E ACTI|VITIES (2021)||||
|---|---|---|---|---|---|---|---|---|
|||||||Unrestricted|Restricted|Total|
|||||||funds|funds|2021|
|||||||E|E|E|
||NHS funding<br>from|CCGs||||998,707||998,707|
||Rapid Personalised|Care||||1,153,620||1,153,620|
||Pepper Foundation/||NHS England||||325,730|325,730|
||COVIO grant funding||through|Hospice|UK||2,729,515|2,729,515|
|||||||2,152,327|3,055,245|5,207,572|
||INCOME FROM CHARITABLE ACTIVITIES (2020)||||||||
|||||||Unrestricted|Restricted|Total|
|||||||funds|funds|2020|
||||||||E|E|
||NHS funding<br>from|CCGs||||1,042,574||1,042,574|
||Rapid Personalised|Care||||2,165,914||2,165,914|
||Pepper Foundation/||NHS England||||346,744|346,744|
|||||||3,208,488|346,744|3,555,232|
|4.|OTHER INCOME|(2021)||||Unrestricted|Restricted|Total|
|||||||funds|funds|2021|
|||||||F.|E|E|
||Hospice Lottery Partnership|||||435,704||435,704|
||Business Continuity||Insurance|Claim||353,654||353,654|
||Council Grant Covid||19|||338,429||338,429|
||Furlough<br>Covid 19|||||417,427||417,427|
||Other Income|||||11,472||11,472|
|||||||1,556,686||1,556,686|
||OTHER INCOME|(2020)||||Unrestricted|Restricted|Total|
|||||||funds|funds|2020|
|||||||E|E||
||Small Business Rates Relief|||||460,000||460,000|
||Hospice Lottery Partnership|||||450,000||450,000|
||Other|||||12,709||12,709|
|||||||922,709||922,709|





## 

|S.|EXPENDITURE|(2021)||Direct staff|Direct other|Allocated|Total|
|---|---|---|---|---|---|---|---|
|||||costs||support costs|2021|
||Costs of raising|donations|and|||||
||Legacies|||591,917|130,812|118,777|841,506|
||Costs oftrading|and fundraising||994,564|1,035,115|267,248|2,296,927|
||Charitable<br>activities|||||||
||Patient care|||4,707,634|420,587|510,741|5,638,962|
|||||6,294,115|1,586,514|896,766|8,777,395|



|EXPENDI'TORE|(2020)||Direct staff|Direct other|Allocated|Total|
|---|---|---|---|---|---|---|
||||costs|costs|support costs|2020|
||||E|E||E|
|Costs of raising|donations|and|601,348|195,127|133,087|929,562|
|legacies|||1,107,265|1,417,936|284,322|2,809,523|
|Costs oftrading|and fundraising||||||
|Charitable<br>activities|||5,483,309|435,754|483,953|6,403,016|
|Patient care|||||||
||||7,191,922|2,048,817|901,362|10,142,101|



## 

||||||||2021|
|---|---|---|---|---|---|---|---|
||||Management|Finance|Resources|Governance|Total|
||||E|E|E|E|E|
|Costs ofraising||||||||
|donations|and legacies||18,459|27,474|69,692|5,250|120,875|
|Costs oftrading||and||||||
|fundraising|||40,442|60,196|152,696|11,503|264,837|
|Charitable|activities|||||||
|Patient care|||78,042|116,160|294,656|22,196|511,054|
||||136,943|203,830|517,044|38,949|896,766|





## 

## 

||ANALYSIS|OFS|UPPO|R|T COSTS(2020)|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||||||2020|
||||||Management||Finance|Resources|Governance||Total|
||||||||E|E||||
||Costs of raising|||||||||||
||donations<br>and legacies|||||20,361|28,717|74,832||7,702|131,612|
||Costs oftrading||and|||||||||
||fundraising||||43,965||62,007|161,583||16,631|284,186|
||Charitable<br>activities|||||||||||
||Patient|care|||75,119||105,946|276,082||28,417|485,564|
||||||139,445||196,670|512,497||52,750|901,362|
|GOVERNANCE<br>COSTS INCLUDE|||||||||2021||2020|
|||||||||||E||
|Insurance||||||||||9,898|11,957|
|Legal|fees|||||||||||
|Professional<br>fees||||||||||6,901|19,953|
|Other|expenses|||||||||||
|Auditor's<br>remuneration:||||||||||||
|Audit work|||||||||18,950||18,050|
|Other services||||||||||3,200|2,790|
||||||||||38,949||52,750|
|7.|NET INCOME|||||||||||
|||||||||2021|||2020|
||Net income|is stated after:|||||||||E|
||Auditors'<br>remuneration|||||||||||
||Audit services||||||||18,950||18,050|
||Other services||||||||3,200||2,790|
||Operating<br>lease||rentals|||||||||
||Land and buildings|||||||586,991|||681,292|
||Depreciation||||||||121,937||135,345|
||Amortisation||||||||100,000||100,000|
|8.|STAFF COSTS|||||||2021|||2020|
|||||||||Number||Number||
||The average|monthly||number ofemployees||for the|charity and the|||||
||group during|the year||was:||||||||
||Direct charitable||work||||||86||80|
||Fundraising|—donations|||and legacies||||20||22|
||Fundraising|—trading||(shop staff)|||||44||46|
||Fundraising|-events||||||||1|1|
||Management|and administration|||||||16||15|
||||||||||167||164|





## 

|Employment|costs in respect ofthe staff above were:|2021|2020|
|---|---|---|---|
|||E|E|
|Wages and|salaries|5,134,462|4,919,588|
|National<br>insurance||421,590|416,795|
|Pensions||275,265|276,547|
|Other costs||223,809|307,651|
|||6,055,126|5,920,581|



## 

||2021||2020||
|---|---|---|---|---|
||Number||Number||
|f60,001- 670,000||1||1|
|f80,001to f90,000||1||1|



## 

## 

## 

## 



|ORT|HE YEAR ENDED 31MARCH 2021||
|---|---|---|
|11.|INTANGIBLE FIXEDASSETS (GROUP AND CHARITY)|Goodwill<br>I|
|||2021|
||Cost||
||At 1 April 2020|500,000|
||Additions||
||At 31 March 2021|500,000|
||Amortisation||
||At 1 April 2020|300,000|
||Charge for the year|100,000|
||At 31March 2021|400,000|
||Net book value||
||At 31March 2021|100,000|
||At 31March 2020|200,000|





## 

|12.<br>TANGIBLE|FIXEDASSETS|||||||
|---|---|---|---|---|---|---|---|
|||Leasehold|Fixtures|||||
||Land and|improve-|and|Tools and|Motor|Work in||
||buildings|ments|fittings|equipment|vehicles|progress|Total|
|||E|||E|E||
|Group:||||||||
|Cost||||||||
|At 1 April 2020<br>Additions|2,050,942<br>196,640|301,129|231,677|362,569|52,436|718,880|3,717,633<br>196,640|
|Disposals||||||||
|Transfer|718,880|||||(718,880)||
|At31March 2021|2,966,462|301,129|231,677|362,569|52,436||3,914,273|
|Depreciation||||||||
|At 1 April 2020<br>Charge for the year|446,020<br>28,380|237,782<br>8,943|156,200<br>33,259|281,923<br>41,034|28,247<br>10,320||1,150,172<br>121,936|
|Disposals||||||||
|At31March 2021|474,400|246,725|189,459|322,957|38,568||1,272,108|
|Net book value||||||||
|At 31 March 2021|2,492,062|54,404|42,218|39,612|13,869||2,642,165|
|At 31 March 2020|1,604,922|63,347|75,477|80,646|24,190|718,880|2,567,461|
|Charity:||||||||
|Cost||||||||
|At 1 April 2020|1,382,341|301,129|231,677|362,569|52,436|718880|3049032|
|Additions|196,640||||||196,640|
|Disposals||||||||
|Transfer|718,880|||||(718,880)||
|At 31March 2021|2,297,861|301,129|231,677|362,569|52,436||3,245,672|
|Depreciation||||||||
|At 1April 2020<br>Charge for the year<br>Retire Assets|324,722<br>21,787|237,782<br>8,943|156,200<br>33,259|281,923<br>41,034|28,247<br>10,321||1,028,874<br>115,344|
|At 31March 2021|346,509|246,725|189,459|322,957|38,568||1,144,218|
|Net book value||||||||
|At 31 March 2021|1,951,352|54,404|42,218|39,612|13,868||2,101,454|
|At 31 March 2020|1,057,619|63,347|75,477|80,646|24,189|718,880|2,020,158|





## 


## 



|14.|STOCK||||Group<br>2021|Group<br>2020|Charity<br>2021|Charity<br>2020|
|---|---|---|---|---|---|---|---|---|
||||||||E||
||Bought<br>in goods for resale||||51,000|50,181|||
|15.|DEBTORS||||Group<br>2021|Group<br>2020|Charity<br>2021|Charity<br>2020|
||||||E||||
||Trade debtors|||||1,575||1,575|
||Income tax recoverable||||19,563|67,341|19,563|67,341|
||Prepayments<br>and accrued|||legacy income|2,932,119|2,328,247|2,932,119|2,328,247|
||Other debtors||||292|214,534|290|214,531|
||Intercompany|debtors|||||47,455|94,449|
||||||2,951,974|2,611,697|2,999,427|2,706,143|
|16a.|CREDITORS: amounts<br>within one year|||falling due|Group<br>2021|Group<br>2020|Charity<br>2021|Charity<br>2020|
||||||E|E|E||
||Trade creditors||||181,637|220,142|179,327|219,551|
||Taxation and social security||||26,961|105,576|26,811|102,585|
||Pensions||||51,218|48,950|51,218|48,950|
||Accruals and deferred||income||803,240|1,083,373|801,740|1,081,873|
||Other creditors||||149||149||
||||||1,063,205|1,458,041|1,059,245|1,452,959|



|Accruals|and deferr|ed<br>income includes<br>deferred<br>income|as follows:||
|---|---|---|---|---|
||||Group L|Group B|
||||Charity|Charity|
||||2021|2020|
||||E|E|
|At 1 April|2020||101,539|50,714|
|Amounts|deferred|in the year|434,285|101,539|
|Amounts|released|in the year|(101,539)|(50,714)|
|At 31March 2021|||434,285|101,539|





## 

## 


## 

## 



|18.|RESERVES2021||||||Gains,||
|---|---|---|---|---|---|---|---|---|
||||||||Losses||
|||||At 1April|||and|At 31|
|||||2020|Income|Expenditure|Transfers|March 2021|
|||||E||E|||
||Group:||||||||
||Unrestricted<br>funds||||||||
||General fund|||5,782,209|8,242,206|(5,090,754)|(452,131)|8,481,530|
||Designated<br>fixed asset fund|||243,659||(1,009,078)|915,520|150,101|
||Designated<br>equipment||fund||||||
||lain Rennie Hospice Services|||13,203|89,335|(44,896)||57,642|
||Restricted funds|||6,039,071|8,331,541|(6,144,728)|'l63,389|8,689,273|
||Property<br>fund|||1,604,922||887,140||2,492,062|
||Other Restricted<br>Funds||—fixed||||||
||assets||||||||
||Pepper Foundation||||325,730|(325,730)|||
||COVID grant funding|through|||||||
||Hospice<br>UK||||2,729,515|(2,729,515)|||
||Nurses Cottage Trust<br>Other restricted<br>funds|||316,041<br>145,519|9,308<br>465,390|(9,308)<br>(455,254)|(21,243)|294,798<br>155,655|
|||||2,066,482|3,529,943|(2,632,667)|(21,243)|2,942,515|
||Total funds|||8,105,553|11,861,484|(8,777,395)|442,146|11,631,788|
||Charity:||||||||
||Unrestricted<br>funds||||||||
||General<br>fund|||5,777,438|8,231,861|(5,080,407)|(452,131)|8,476,761|
||Designated<br>fixed asset||fund|243,659||(1,009,078)|915,520|150,101|
||Designated<br>equipment||fund||||||
||Restricted funds|||6,021,097|8,231,861|(6,089,485)|463,389|8,626,862|
||Pepper Foundation||||325,730|(325,730)|||
||COVID grant funding|through|||||||
||Hospice<br>UK||||2,729,515|(2,729,515)|||
||Property<br>fund|||1,057,621||893,731||1,951,352|
||Nurses Cottage Fund<br>Other restricted<br>funds|||316,041<br>145,517|9,308<br>465,390|(9,308)<br>(455,254)|(21,243)|294,798<br>155,653|
|||||1,519,179|3,529,943|(2,626,076)|(21,243)|2,401,803|
||Totalfunds|||7,540,276|11,761,804|(8,715,561)|442,146|11,028,665|





## 

|18.|RESERVES2020|RESERVES2020|||||Gains,||
|---|---|---|---|---|---|---|---|---|
||||||||Losses||
|||||At 1April|||and|At31|
|||||2019|Income|Expenditure|Transfers|March 2020|
|||||E|E|F.||E|
||Group:||||||||
||Unrestricted|funds|||||||
||General fund|||4,437,279|10,443,394|(8,824,227)|(274,237)|5,782,209|
||Designated<br>fixed asset||fund|287,520||(112,469)|68,608|243,659|
||Designated<br>equipment||fund|2,245||(2,245)|||
||lain Rennie Hospice Services|||13,203|160,525|(160,525)||13,203|
|||||4,740,247|10,603,919|(9,099,466)|(205,629)|6,039,071|
||Restricted funds||||||||
||Property<br>fund|||1,625,553||(20,631)||1,604,922|
||Pepper Foundation||||346,744|(346,744)|||
||Nurses Cottage|Trust||299,397|9,308|(9,308)|16,644|316,041|
||Other restricted|funds||160,703|650,768|(665,952)||145,519|
|||||2,085,653|1,006,820|(1,042,635)|16,644|2,066,482|
||Total funds|||6,825,900|11,610,739|(10,142,101)|(188,985)|8,105,553|
||Charity:||||||||
||Unrestricted|funds|||||||
||General fund|||4,409,739|10,542,034|(8,900,098)|(274,237)|5,777,438|
||Designated<br>fixed asset||fund|287,520||(112,469)|68,608|243,659|
||Designated<br>equipment||fund|2,245||(2,245)|||
|||||4,699,504|10,542,034|(9,014,812)|(205,629)|6,021,097|
||Restricted funds||||||||
||Property<br>fund|||1,085,700|346,744|(346,744)||1,085,700|
||Other fixed assets|||(14,039)||(14,040)||(28,079)|
||Nurses Cottage|Fund||299,397|9,308|(9,308)|16,644|316,041|
||Other restricted|funds||160,702|650,767|(665,952)||145,517|
|||||1,531,760|1,006,819|(1,036,044)|16,644|1,519,179|
||Total funds|||6,231,264|11,548,853|(10,050,856)|(188,985)|7,540,276|





## 

## 

## 

## 

## 

## 

## 

## 



|19.|ANALYSIS OF NET ASSETS BYFUND (2021)|Unrestricted|Restricted||
|---|---|---|---|---|
|||funds|funds|Total|
|||E|E|E|
||Group:||||
||Intangible<br>fixed assets|100,000||100,000|
||Tangible fixed assets|150,101|2,492,064|2,642,165|
||Investments|2,501,402|294,796|2,796,198|
||Other net assets|5,937,770|155,655|6,093,425|
||Total net assets|8,689,273|2,942,515|11,631,788|
||Charity:||||
||Intangible<br>fixed assets|100,000||100,000|
||Tangible fixed assets|150,101|1,951,353|2,101,454|
||Investments|2,501,404|294,796|2,796,200|
||Other net assets|5,875,356|155,655|6,031,011|
||Total net assets|8,626,862|2,401,803|11,028665|
||ANALYSIS OF NET ASSETS BYFUND (2020)|Unrestricted|Restricted||
|||funds|funds|Total|
||Group:||||
||Intangible<br>fixed assets|200,000||200,000|
||Tangible<br>fixed assets|962,538|1,604,923|2,567,461|
||Investments|2,043,884|316,041|2,359,925|
||Other net assets|2,832,648|145,518|2,978,166|
||Total net assets|6,039,070|2,066,482|8,105,552|
||Charity:||||
||Intangible<br>fixed assets|200,000||200,000|
||Tangible fixed assets|962,538|1,057,620|2,020,158|
||Investments|2,0'l3,886|316,041|2,359,927|
||Other net assets|2,814,673|145,518|2,960,191|
||Total net assets|6,021,097|1,519,179|7,540,276|





## 

|||Income|Expenditure|Netfunds|
|---|---|---|---|---|
|||E||E|
|St Albans and Dacorum|Day Hospice|||4,772|
|Iain Rennie Hospice at|Home||6,591|540,711|
|Iain Rennie Hospice Services||89,335|55,243|57,642|



## 

## 

## 

## 

||Land and|buildings|
|---|---|---|
||2021|2020|
||F.|E|
|Expiry date:|||
|Within one year|665,906|666,395|
|Between one and two years|574,446|622,336|
|Between two and five years|1,005,616|1,197,963|
|In over five years|670,286|892,689|
||2,916,254|3,379,383|





## 

|||||||||2021|2020|
|---|---|---|---|---|---|---|---|---|---|
||GROUP:|||||||E||
||Financial assets at amortised<br>cost|||||||4,966,774|1,990,437|
||Financial<br>liabilities at amortised|cost||||||235,315|269,092|
||Financial assets at fair value|||||||2,537,391|2,101,117|
||Equity instrument<br>at cost less impairment|||||||258,806|258,806|
||CHARITY:|||||||||
||Financial assets at amortised<br>cost|||||||4,903,948|1,923,114|
||Financial<br>liabilities at amortised|cost||||||199,150|179,638|
||Financial asset at fair value|||||||2,537,391|2,101,117|
||Equity instrument<br>at cost less impairment|||||||258,808|258,808|
|24.|NOTES TO THE CASHFLOW STATEMENT|||||||2021|2020|
||||||||||E|
||Reconciliation<br>of<br>changes||in|resources|to|net|cash|||
||inflow/(outflow)<br>from operating||activities|||||||
||Net income for reporting<br>period|||||||3,526,235|1,279,653|
||Depreciation<br>oftangible<br>fixed assets|||||||121,936|135,345|
||Amoitisation<br>ofintangible<br>fixed|assets||||||100,000|100,000|
||(Gains)/Losses<br>on investments|||||||(441,968)|199,096|
||Interest received|||||||(439)|(4,873)|
||Dividends<br>received|||||||(9,737)|(10,737)|
||Realised (Gains)/Loss|||||||(176)|(10,110)|
||(Increase)/Decrease<br>in stock|||||||(819)|(17,666)|
||Decrease/(Increase)<br>in debtors|||||||(340,278)|(1,585,655)|
||(Decrease)/Increase<br>in creditors|||||||(394,836)|679,376|
||Net cash generated<br>by operating|activities||||||2,559,918|764,429|





## 

||||Unrestricted|Restricted|Total|
|---|---|---|---|---|---|
||||Funds|Funds|2020|
|||Notes||||
|INCOME FROM:||||||
|Donations<br>and legacies||2|2,581,064|646,818|3,227,882|
|Charitable<br>activities||3||||
|NHS funding|||1,042,574||1,042,574|
|Rapid Personalised<br>Care|||2,165,914||2,165,914|
|Other income from charitable<br>activities||||346,744|346,744|
|Other trading activities||||||
|Events 5community|||605,944|3,950|609,894|
|Retail income|||3,279,412||3,279,412|
|Investments|||6,302|9,308|15,610|
|Other||||||
|Hospice Lottery Partnership|||450,000||450,000|
|Other income|||472,709||472,709|
|Total income|||10,603,919|1,006,820|11,610,739|
|EXPENDITURE ON:||||||
|Raising funds||||||
|Donations<br>and legacies|||929,562||929,562|
|Fundraising<br>activities|||2,809,523||2,809,523|
|Charitable<br>activities||||||
|Patient care|||3,'l89,811|1,042,635|4,532,446|
|Rapid Personalised<br>Care|||1,870,570||1,870,570|
|Total expenditure|||9,099,466|1,042,635|10,142,101|
|Net gains/(losses)<br>on|investments||(205,629)|16,644|(188,985)|
|Net income/(expenditure)|||1,298,824|(19,171)|1,279,653|
|Transfers between|funds|||||
|Other recognised gains/(losses)||||||
|Net movement<br>in funds|||1,298,824|(19,171)|1,279,653|
|Funds brought<br>forward|||4,740,247|2,085,653|6,825,900|
|Funds at 31 March 2020|||6,039,071|2,066,482|8,105,553|



